ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 139 filers reported holding ARRAY BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 3.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,142,000 | +8.3% | 110,987 | -43.0% | 0.01% | 0.0% |
| Q1 2019 | $4,749,000 | +71.1% | 194,783 | 0.0% | 0.01% | +57.1% |
| Q4 2018 | $2,776,000 | -6.2% | 194,783 | 0.0% | 0.01% | +16.7% |
| Q3 2018 | $2,960,000 | -37.6% | 194,783 | -31.0% | 0.01% | +20.0% |
| Q2 2018 | $4,740,000 | +107.4% | 282,398 | +101.7% | 0.01% | 0.0% |
| Q1 2018 | $2,285,000 | -70.2% | 140,004 | -76.7% | 0.01% | -44.4% |
| Q4 2017 | $7,680,000 | +83.6% | 600,056 | +76.4% | 0.01% | -10.0% |
| Q3 2017 | $4,184,000 | -37.8% | 340,168 | -57.7% | 0.01% | -37.5% |
| Q2 2017 | $6,730,000 | +28.5% | 804,009 | +37.3% | 0.02% | +33.3% |
| Q1 2017 | $5,236,000 | +163.9% | 585,702 | +159.4% | 0.01% | +140.0% |
| Q4 2016 | $1,984,000 | +118.0% | 225,763 | +67.4% | 0.01% | +150.0% |
| Q3 2016 | $910,000 | -0.7% | 134,841 | -30.3% | 0.00% | 0.0% |
| Q4 2014 | $916,000 | +31.8% | 193,585 | -0.6% | 0.00% | +100.0% |
| Q3 2014 | $695,000 | -20.2% | 194,707 | +2.0% | 0.00% | -50.0% |
| Q2 2014 | $871,000 | -2.9% | 190,981 | +0.1% | 0.00% | 0.0% |
| Q1 2014 | $897,000 | -10.7% | 190,719 | -4.9% | 0.00% | 0.0% |
| Q4 2013 | $1,005,000 | -81.8% | 200,514 | -77.4% | 0.00% | -86.7% |
| Q3 2013 | $5,513,000 | +34.7% | 886,363 | -1.7% | 0.02% | +25.0% |
| Q2 2013 | $4,094,000 | – | 901,846 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |